“Relapse”的搜索结果，显示 81-90 项，共有 2545 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Relapsed/Refractory Multiple Myeloma (RRMM). A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Relapsed/Refractory Multiple Myeloma (RRMM). A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Relapsed/Refractory Multiple Myeloma (RRMM). A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic ...

4. CAR-T 细胞疗法计划- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

5. 泌尿科- 临床试验- 妙佑医疗国际

   Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Rare ...

6. 泌尿科- 临床试验- 妙佑医疗国际

   Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Rare ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

9. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...